CING logo

Cingulate (CING)

Profile

Full Name

Cingulate Inc.

Ticker Symbol

CING

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 8, 2021

Indexes

Not included

Website

http://www.cingulate.com

Employees

13

Key Details

Price

$3.92(+3.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$10.20(+96.73% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.92
CING price is $3.92

30-Day Relative Volume

0.79
CING 30-day relative volume is 0.79

Price Performance

Price Today change

+3.16%
CING price is up +3.16% today

Price YTD change

-20.49%
CING price is down -20.49% since January 1st

Price 1-year change

-64.53%
CING price is down -64.53% year-on-year

Price 3-year change

-99.08%
CING price is down -99.08% over the past 3 years

Price Range

Price All-time high

$1068.00
CING price is currently -99.63% below its historical high of $1068.00

Price 3-year low

$0.28
CING price is currently +1280.28% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$14.30M
CING market capitalization is $14.30 million

Market cap 3-year change

-28.53%
CING market capitalization is down -28.53% over the past 3 years

Market cap All-time high

$50.30M
CING market capitalization is currently -71.57% below its historical high of $50.30 million

Market cap sector rank

24.4%
CING market capitalization is higher than 24.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+773.7%
CING shares outstanding is up +773.7% year-on-year

Shares Outstanding 3-Year Change

+7644.59%
CING shares outstanding is up +7644.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.27
CING beta is 1.27

200-day SMA

$4.78
CING price is currently -18.05% below its 200-day simple moving average

50-day SMA

$4.09
CING price is currently -4.16% below its 50-day simple moving average

RSI

44.33
CING 14-day relative strength index is 44.33

Volume

0.79
CING 30-day relative volume is 0.79

ATR

$0.29
CING average true range is $0.29

10-day Historical Volatility

49.70%
CING 10-day historical volatility is 49.70%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CING annual revenue value is unknown

Revenue Analysts estimate

-
CING annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CING annual revenue 1-year change is unknown

Revenue Sector rank

-
CING annual revenue is unknown

EPS

EPS

-$10.20
CING annual earnings per share is -$10.20

EPS Analysts estimate

-$2.90
CING annual earnings per share is currently +252.12% higher than the consensus analysts' forecast

EPS 1-year change

+96.73%
CING annual earnings per share is up +96.73% year-on-year

EPS Sector rank

12.06%
CING annual earnings per share is higher than 12.06% of companies in Healthcare sector

Profit

Gross profit

-
CING annual gross profit value is unknown

Gross margin

-
CING annual gross profit margin value is unknown

Operating profit

-$15.65M
CING annual operating income is -$15.65 million

Operating margin

-
CING annual operating profit margin value is unknown

Net income

-$15.55M
CING annual net profit is -$15.55 million

Net margin

-
CING annual net profit margin value is unknown

Expenses

Total expenses

$15.65M
CING annual total expenses is $15.65 million

Operating expenses

$15.65M
CING annual total operating expenses is $15.65 million

Cost of goods sold

-
CING annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.20M
CING annual SGA is $6.20 million

Depreciation and amortization

$653.10K
CING annual depreciation & amortization is $653.10 thousand

Interest expense

-
CING annual interest expense value is unknown

Income tax

$0.00
CING annual income tax is $0.00

EBIT & EBITDA

EBIT

-$15.65M
CING annual earnings before interest & taxes is -$15.65 million

EBITDA

-$14.99M
CING annual EBITDA is -$14.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$14.86M
CING annual total assets is $14.86 million

Non current assets

$2.20M
CING annual long term assets is $2.20 million

Current assets

$12.66M
CING annual total current assets is $12.66 million

Cash and cash equivalents

$12.21M
CING annual cash & cash equivalents is $12.21 million

Accounts receivable

-
CING annual accounts receivable value is unknown

Inventory

-
CING annual inventory value is unknown

Liabilities

Total liabilities

$7.41M
CING annual total liabilities is $7.41 million

Long term liabilities

$2.44M
CING annual total long term liabilities is $2.44 million

Current liabilities

$4.97M
CING annual total current liabilities is $4.97 million

Accounts payable

$1.27M
CING annual accounts payable is $1.27 million

Debt

Total debt

$5.10M
CING annual total debt is $5.10 million

Total debt 1-year change

+45.27%
CING annual total debt is up +45.27% year-on-year

Long term debt

$2.44M
CING annual long term debt is $2.44 million

Short term debt

$2.66M
CING annual short term debt is $2.66 million

Equity & Capital

Shareholders equity

$7.46M
CING annual stockholders equity is $7.46 million

Book value

$7.46M
CING annual book value is $7.46 million

Retained earnings

-$108.49M
CING annual retained earnings is -$108.49 million

Working capital

$7.69M
CING annual working capital is $7.69 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$18.45M
CING annual cash flow from operations is -$18.45 million

Cash from operations 1-year change

-22.73%
CING annual cash flow from operations is down -22.73% year-on-year

Cash from investing

-$211.80K
CING annual cash flow from investing activities is -$211.80 thousand

Cash from investing 1-year change

+5.49%
CING annual cash flow from investing activities is up +5.49% year-on-year

Cash from financing

$30.82M
CING annual cash flow from financing activities is $30.82 million

Cash from financing 1-year change

+209.62%
CING annual cash flow from financing activities is up +209.62% year-on-year

CAPEX

CAPEX

-
CING annual capital expenditures value is unknown

CAPEX 1-year change

-
CING annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$18.66M
CING annual free cash flow is -$18.66 million

Free cash flow 1-year change

-22.31%
CING annual free cash flow is down -22.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CING annual gross profit margin value is unknown

Operating margin

-
CING annual operating profit margin value is unknown

Net margin

-
CING annual net profit margin value is unknown

ROA & ROE

ROA

-104.58%
CING annual return on assets is -104.58%

ROE

-208.51%
CING annual return on equity is -208.51%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CING price to earnings ratio value is unknown

PE ratio Sector rank

-
CING price to earnings ratio is unknown

PB Ratio

PB ratio

1.92
CING price to book ratio is 1.92

PB ratio Sector rank

61.35%
CING price to book ratio is higher than 61.35% of companies in Healthcare sector

PS Ratio

PS ratio

-
CING price to sales ratio value is unknown

PS ratio Sector rank

-
CING price to sales ratio is unknown

Enterprise value

Enterprise value

$7.19M
CING enterprise value is $7.19 million

Enterprise value Sector rank

22.13%
CING enterprise value is higher than 22.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.48
CING EV/EBITDA is -0.48

EV/EBITDA Sector rank

52.04%
CING EV/EBITDA is higher than 52.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.55
CING annual current ratio is 2.55

Quick ratio

-
CING annual quick ratio value is unknown

Leverage

Debt to equity

0.68
CING annual debt to equity ratio is 0.68

Interest coverage ratio

-
CING annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CING piotroski f-score value is unknown

Altman Z-Score

-
CING altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 6, 25 HC Wainwright & Co.
Buy
Jan 30, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Roth MKM
Buy
Nov 20, 24 Maxim Group
Buy
Jan 5, 24 HC Wainwright & Co.
Buy
Dec 22, 23 Laidlaw & Co.
Hold
Dec 19, 23 Maxim Group
Hold
Dec 18, 23 Maxim Group
Hold
Sep 26, 23 HC Wainwright & Co.
Buy
Jan 17, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Abpro (ABP)
CLDI logo
Calidi Biotherapeutics (CLDI)
VVOS logo
Vivos Therapeutics (VVOS)
AXDX logo
Accelerate Diagnostics (AXDX)
BNGO logo
Bionano Genomics (BNGO)
PRTG logo
Portage Biotech (PRTG)
AXLA logo
Axcella Health (AXLA)
PHGE logo
BiomX (PHGE)
MIRA logo
MIRA Pharmaceuticals (MIRA)
  • What is the ticker symbol for Cingulate?
  • Does Cingulate pay dividends?
  • What sector is Cingulate in?
  • What industry is Cingulate in?
  • What country is Cingulate based in?
  • When did Cingulate go public?
  • Is Cingulate in the S&P 500?
  • Is Cingulate in the NASDAQ 100?
  • Is Cingulate in the Dow Jones?
  • When does Cingulate report earnings?
  • Should I buy Cingulate stock now?

What is the ticker symbol for Cingulate?

The ticker symbol for Cingulate is NASDAQ:CING

Does Cingulate pay dividends?

No, Cingulate does not pay dividends

What sector is Cingulate in?

Cingulate is in the Healthcare sector

What industry is Cingulate in?

Cingulate is in the Biotechnology industry

What country is Cingulate based in?

Cingulate is headquartered in United States

When did Cingulate go public?

Cingulate's initial public offering (IPO) was on December 8, 2021

Is Cingulate in the S&P 500?

No, Cingulate is not included in the S&P 500 index

Is Cingulate in the NASDAQ 100?

No, Cingulate is not included in the NASDAQ 100 index

Is Cingulate in the Dow Jones?

No, Cingulate is not included in the Dow Jones index

When does Cingulate report earnings?

The date for Cingulate's next earnings report has not been announced yet

Should I buy Cingulate stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page